中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2014年
2期
74-75,76
,共3页
宫颈癌%放射治疗%健康宣教指导
宮頸癌%放射治療%健康宣教指導
궁경암%방사치료%건강선교지도
Cervical cancer%Radiotherapy%Health education guiding
目的:探讨晚期宫颈癌患者放射治疗中的护理干预方法。方法:回顾性分析全疗程放疗的宫颈癌患者206例病例资料,采用盆腔外照射及腔内后装放射治疗相结合的治疗方法。针对患者在治疗中出现的不良反应给予相应的护理干预方法,并观察其对患者的影响。结果:206例患者中有40例(占19.4%)出现骨髓抑制,34例(占16.5%)出现胃肠道反应,15例(占7.3%)出现皮肤及阴道炎症反应,10例(占4.7%)出现泌尿系统反应。经过规范化的护理干预后无1例出现严重并发症。结论:经过科学合理的护理干预方法,能够降低宫颈癌患者在放射治疗中的不良反应。
目的:探討晚期宮頸癌患者放射治療中的護理榦預方法。方法:迴顧性分析全療程放療的宮頸癌患者206例病例資料,採用盆腔外照射及腔內後裝放射治療相結閤的治療方法。針對患者在治療中齣現的不良反應給予相應的護理榦預方法,併觀察其對患者的影響。結果:206例患者中有40例(佔19.4%)齣現骨髓抑製,34例(佔16.5%)齣現胃腸道反應,15例(佔7.3%)齣現皮膚及陰道炎癥反應,10例(佔4.7%)齣現泌尿繫統反應。經過規範化的護理榦預後無1例齣現嚴重併髮癥。結論:經過科學閤理的護理榦預方法,能夠降低宮頸癌患者在放射治療中的不良反應。
목적:탐토만기궁경암환자방사치료중적호리간예방법。방법:회고성분석전료정방료적궁경암환자206례병례자료,채용분강외조사급강내후장방사치료상결합적치료방법。침대환자재치료중출현적불량반응급여상응적호리간예방법,병관찰기대환자적영향。결과:206례환자중유40례(점19.4%)출현골수억제,34례(점16.5%)출현위장도반응,15례(점7.3%)출현피부급음도염증반응,10례(점4.7%)출현비뇨계통반응。경과규범화적호리간예후무1례출현엄중병발증。결론:경과과학합리적호리간예방법,능구강저궁경암환자재방사치료중적불량반응。
Objective:To investigate the nursing methods in radiotherapy in advanced cervical cancer. Methods: Two hundred and nine cervical cancer were retrospectively selected in the department of Radiotherapy in Beijing Obstetrics and Gynecology Hospital, Capital Medical University from June 2009 to December 2012, of which 150 cases of stage IIb, IIIa of 30 cases, IIIb 26 cases. All the patients were treated with external beam pelvic radiotherapy and intracavitary after loading combined. Total radiation dose is about 75-80Gy. The corresponding nursing methods were given according to the different side-reaction. The effect of the nursing methods was observed in the radiotherapy patients. Results:Among 40 cases (19.4%) underwent bone marrow suppression, 34 cases (16.5%) had gastrointestinal reactions, 15 cases (7.3%) had skin and vaginal inflammation, 10 cases (4.7%) of urinary system response. After standardization nursing, none of the patients died for serious complications. Conclusion:After proper methods of care can reduce the side effects of radiotherapy in patients with cervical cancer.